Скачать с ютуб Minoxidil and antiandrogen therapy can improve hair density in chemotherapy-induced alopecia в хорошем качестве

Minoxidil and antiandrogen therapy can improve hair density in chemotherapy-induced alopecia

A recent case series published in the journal JAMA Dermatology has outlined previously unreported features of persistent chemotherapy-induced alopecia (pCIA) in breast cancer patients, including a trichoscopic description. For a significant proportion of patients with topical or systemic treatments, cosmetically significant regrowth was achieved. This suggests that pCIA may be at least partly reversible. According to the study, hair follicle miniaturization which is the hallmark of androgenetic alopecia is a prominent feature in pCIA; recognized androgenetic alopecia treatments, including minoxidil and antiandrogen therapy, can also improve hair density for patients with pCIA. Many people with breast cancer temporarily lose their hair after treatment with chemotherapy, but persistent hair loss is more common in patients who undergo taxane- and cyclophosphamide-based chemotherapy. However, persistent chemotherapy-induced alopecia (pCIA) tends to be underacknowledged by oncologists. For more information: https://medicaldialogues.in/dermatolo... Get the latest medical and heath news at medicaldialogues.in Follow us on Twitter:   / medicaldialogs   Facebook:   / medicaldialo.  . Instagram:   / medicaldial.  . LinkedIn:   / medi.  . Website: https://medicaldialogues.in/